Home
  • Donate money to KEI
  • Listserves
  • Main Areas of Work
  • Videos
  • Events
  • Publications
  • Blogs
  • About KEI

Knowledge Ecology International

Attending and mending the knowledge ecosystem

Navigation

  • Site Map
  • Recent posts
  • Feed aggregator
  • Polls
  • Groups

Round II of the Paris Accord took place in Paris on October 23 and 24, 2009.

Book navigation

  • Copyright and Related Rights
  • About KEI
  • Access to Medical Technologies
  • Competition Policy
  • Databases
  • Economics of Creativity and Knowledge
  • Enforcement and Remedies to Infringement
  • Events
  • General Access to Knowledge Issues
  • Government Funded Inventions
  • Knowledge Governance Fora
    • The Anti-Counterfeiting Trade Agreement (ACTA)
    • World Intellectual Property Organization (WIPO)
    • European Union
    • Non Communicable Disease (NCD) negotiations
    • PAIPO
    • Trans-Pacific Partnership Agreement (TPPA)
    • UNESCO
    • United States Trade Representative (USTR)
    • World Health Organization (WHO)
      • CEWG: WHO Consultative Expert Group on R&D Financing
      • Expert Working Group on R&D Financing
      • 1998/1999 debate over 52.19, the WHO Revised Drug Strategy
      • KEI March 2, 2007 letter to WHO on the Model Essential Medicines List
      • The World Health Assembly takes step back, but leaves door open, for medical R&D Treaty
      • Views on the 60th World Health Assembly IGWG resolution
      • Views on the 61st World Health Assembly adoption of Global Strategy on Public Health, Innovation and Intellectual Property
      • WHO issues mild statement on transit of medicines
      • Why does Bill Gates oppose discussions of a medical R&D treaty at the World Health Organization?
      • WikiLeaks cable details UK/US strategy during IGWG negotiations in 2007
    • World Trade Organization (WTO)
  • Medical diseases, conditions and technologies
  • Nuclear Proliferation
  • Patent Policy
  • Prizes to stimulate innovation
  • Publications and Research Notes
  • Timelines
  • Transparency

User login

What is OpenID?
  • Log in using OpenID
  • Cancel OpenID login
  • Request new password
Home » Knowledge Governance Fora

World Health Organization (WHO)

  • View
  • What links here
  • WHO
  • CEWG: WHO Consultative Expert Group on R&D Financing
  • Expert Working Group on R&D Financing
  • 1998/1999 debate over 52.19, the WHO Revised Drug Strategy
  • KEI March 2, 2007 letter to WHO on the Model Essential Medicines List
  • The World Health Assembly takes step back, but leaves door open, for medical R&D Treaty
  • Views on the 60th World Health Assembly IGWG resolution
  • Views on the 61st World Health Assembly adoption of Global Strategy on Public Health, Innovation and Intellectual Property
  • WHO issues mild statement on transit of medicines
  • Why does Bill Gates oppose discussions of a medical R&D treaty at the World Health Organization?
  • WikiLeaks cable details UK/US strategy during IGWG negotiations in 2007
‹ USTR's 2012 Special 301 Report, focuses on largest developing country markets, and Canada up CEWG: WHO Consultative Expert Group on R&D Financing ›
  • Printer-friendly version
  • Send by email

Support KEI

WASHINGTON 1621 Connecticut Ave. NW, Suite 500, Washington, DC 20009 /TEL: +1.202.332.2670 · FAX +1.202.332.2673 GENEVE 1 Route des Morillons, CP 2100, 1211 Genève 2, Switzerland TEL: +41.22.791.6727
THEME DESIGN Copyright © 2009 under GPL by Tribute Media. Site Powered by Drupal.